Multiomics – News and Features

Past CFO of Myriad Genetics joins preeminent team at Dr. Lee Hood-founded molecular diagnostics company.

Cellzome appoints Professors Ruedi Aebersold; Anne Ferguson-Smith; Jeannie Lee and Diane Mathis to Scientific Advisory Board.

Company has introduced SureSelect RNA Capture Kits, enabling geneticists to focus on specific genomic loci or transcripts of research interest.

New CMO to lead rapid development and commercialization of blood-based diagnostics for lung cancer and Alzheimer's disease.

Investigators used Systems biology approaches together with global expression data sets to identify perturbed gene networks. This provided some understanding of the underlying mechanisms, and to develop specific hypotheses relevant to these chronic lung diseases.

The 3rd Personalized Medicine World Conference™ 2011 Aligns Leaders From Biopharma Industry, Investment, Research, Providers, and Regulatory Communities to Accelerate Personalized Medicine.

Data from a non-targeted biochemical profiling platform was combined with data collected from targeted metabolomics platforms to identify metabolic signatures that are associated with Type 2 diabetes. The proof of concept study illustrates the value of using metabolomics to identify biochemical pathways affected by Type 2 diabetes.

Integromics, a market leader in IT solutions provision for life sciences in the field of genomics and proteomics, today announces that the Princeton Mass Spectrometry Center has purchased a license for the Integromics’ OmicsHub Proteomics solution.

An intriguing study published in Expert Review of Anticancer Therapy has revealed that the signaling protein JAK3 represents a viable target in the treatment of a broad range of B-lineage cancers, including acute lymphoblastic leukemia (ALL).

Tinkering with a single gene may give perennial grasses more robust roots and speed up the timeline for creating biofuels